Schedule 13G ownership disclosure

CAMP4 Therapeutics Corp.

Common stock, par value $0.0001 per share · CUSIP: 13463J101

Event date: 2025-09-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LP

    Shares: 4,886,722.00 · Class: 9.99%

  • Coastlands Capital Partners LP

    Shares: 4,886,722.00 · Class: 9.99%

  • Coastlands Capital GP LLC

    Shares: 4,886,722.00 · Class: 9.99%

  • Coastlands Capital LLC

    Shares: 4,886,722.00 · Class: 9.99%

  • Matthew D. Perry

    Shares: 4,886,722.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-120225
Form type
SCHEDULE 13G/A
Filer
Camp4 Therapeutics Corp
CIK
CIK 1736730
Filed
Dec 11, 2025
Reporting period
Sep 10, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub